Evidence map›Paper›PMID 30377371›Full record

ArticleNature methods2018

A high-throughput pipeline for validation of antibodies.

Krzysztof Sikorski, Adi Mehta, Marit Inngjerdingen, Flourina Thakor, Simon Kling, Tomas Kalina, Tuula A Nyman, Maria Ekman Stensland, Wei Zhou, Gustavo A de Souza and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Krzysztof SikorskiDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0003-2112-2093
Adi MehtaDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Marit InngjerdingenDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Flourina ThakorDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Simon KlingNMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
Tomas KalinaCLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-4475-2872
Tuula A NymanDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8787-5886
Maria Ekman StenslandDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Wei ZhouSeekQuence, Mountain View, CA, USA.
Gustavo A de SouzaThe Brain Institute, Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Lars HoldenNorwegian Computing Center, Oslo, Norway.
Jan StuchlyCLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic.
Markus TemplinNMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany.
Fridtjof Lund-JohansenDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway. fridtjol@gmail.com.ORCID http://orcid.org/0000-0002-2445-1258

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Western blotting (WB) is widely used to test antibody specificity, but the assay has low throughput and precision. Here we used preparative gel electrophoresis to develop a capture format for WB. Fractions with soluble, size-separated proteins facilitated parallel readout with antibody arrays, shotgun mass spectrometry (MS) and immunoprecipitation followed by MS (IP-MS). This pipeline provided the means for large-scale implementation of antibody validation concepts proposed by an international working group on antibody validation (IWGAV).

Indexed as

AntibodiesHigh-Throughput Screening AssaysHumansImmunoprecipitationMass SpectrometryNeoplasm ProteinsNeoplasmsProteomicsTumor Cells, CulturedAntibodiesNeoplasm Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.